Atrial fibrillation following intravenous zolendronic acid for osteoporosis.
Department of Rheumatology Veterans Administration Hospital (NIMTS) Athens, Greece markonsta@hotmail.com.
Maria
M
Konsta
Vasiliki-Kalliopi
VK
Bournia
Vasiliki
V
Dania
Alexios
A
Iliopoulos
D061605:Administration, Intravenous; D000368:Aged; D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000139:chemically induced*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D012189:Retrospective Studies; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid